GT Biopharma (GTBP) Requests Withdrawal of Form S-1 Registration Statement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. AMZN
2. INTC
3. COIN
4. PINS
5. RDDT
6. FSLR
7. SNDK
8. FND
9. DASH
10. RBLX

Go back to GT Biopharma (GTBP) Requests Withdrawal of Form S-1 Registration Statement

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

February 25, 2025 7:00 AM EST

SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the Company) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced that it has filed a Request for Withdrawal with the U.S. Securities and Exchange Commission (SEC) with respect to the withdrawal of the Companys Registration Statement on Form S-1 (File No. 333-284032) that it filed with the SEC originally on December 23, 2024. The Registration Statement has not been declared effective by the SEC,... More